RETRACTION : Polygenic Risk Score and Prostate Specific Antigen Predict Death From Prostate Cancer in Men With Intermediate Aggressive Cancer
International Journal of Cancer · 01.09.2026 · 159 (5) · 1348-1348
DOI: 10.1002/ijc.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 10.06.2026.
Abstract (Originalsprache)
RETRACTION : L. R. Santiago , E. Ladoukakis , D. Scibior‐Bentkowska , and B. Nedjai , “,” International Journal of Cancer (Early View): 10.1002/ijc.70163 . The above article, published online on 16 September 2025 in Wiley Online Library ( wileyonlinelibrary.com ), has been retracted by agreement between the authors; the journal Editor‐in‐Chief, Christoph Plass; the Union for International Cancer Control; and John Wiley & Sons Ltd. The retraction was agreed upon following the authors’ communication to the journal that methodological errors had been identified after publication that were found to have altered outcomes regarding statistical significance and reproducibility of the results presented. Accordingly, the article has been retracted.
Zitieren
APA
(2026). RETRACTION : Polygenic Risk Score and Prostate Specific Antigen Predict Death From Prostate Cancer in Men With Intermediate Aggressive Cancer. International Journal of Cancer, 159(5), 1348-1348. https://doi.org/10.1002/ijc.70578
Vancouver
RETRACTION : Polygenic Risk Score and Prostate Specific Antigen Predict Death From Prostate Cancer in Men With Intermediate Aggressive Cancer. International Journal of Cancer. 2026;159(5):1348-1348. doi:10.1002/ijc.70578
BibTeX
@article{euvimed2026,
title = {RETRACTION : Polygenic Risk Score and Prostate Specific Antigen Predict Death From Prostate Cancer in Men With Intermediate Aggressive Cancer},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {5},
pages = {1348--1348},
doi = {10.1002/ijc.70578}
}
EUVIMED